Depression 7 - Others

Sun. May 26, 2024 1:30 PM - 2:30 PM CINP Poster Session Hall (Lobby Gallery)

+Add all to schedule

[P460] Development of an XAI-Based Computer-Aided Diagnostic System for Drug-Naïve Male MDD Patients

*Eun-Gyoung Yi^1,2,3, Miseon Shim⁶, Hyeon-Ho Hwang³, Sunhae Jeon³, Han-Jeong Hwang^1,2, Seung-Hwan Lee^3,4,5 (1. Department of Electronics and Information Engineering, Korea University , 2. Artificial Intelligence Smart Convergence Technology, Korea University , 3. Clinical Emotion and Cognition Research Laboratory, Department of Psychiatry, Inje University, 4. Psychiatry Department, Ilsan Paik Hospital, Inje University, 5. Bwave Inc, Goyang, 6. Department of Artificial Intelligence, Tech University of Korea)

[P462] Role of Microsomal prostaglandin E synthase-1 in mouse models of stress

*Yuri Ikeda-Matsuo¹, Hina Takagi¹, Yuta Kawabata¹, Saki Iwato¹, Asumi Doumae¹, Shizuo Akira², Satoshi Uematsu³, Tatsuo Takahashi¹ (1. Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University, 2. WPI Immunology Frontier Research Center, Osaka University, 3. Department of Immunology and Genomics, Osaka Metropolitan University Graduate School of Medicine)

[P464] Immunometabolic profiling of developmental trajectory subgroups of depressive symptoms in ALSPAC

*Ruby Tsang¹, Nicholas Timpson¹, Golam Khandaker¹ (1. MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom)

[P465] Incidence of Depressive and Anxiety Symptoms among Elderly Filipinos during the COVID-19 Pandemic: A Descriptive Cross-Sectional Study

*Hecil Abobo Cruz¹, Robert Delfin Buenaventura¹, Melissa Paulita Villaflor Mariano¹ (1. Department of Psychiatry, University of the East Ramon Magsaysay Memorial Medical Center Inc., Quezon City, Philippines)

[P466] Epidemiology and burden of disease of Major Depressive Disorder (MDD) with anhedonia in Asia Pacific

*Keira Joann Herr¹, Michael Berk², Wei-Lieh Huang³, Tadafumi Kato⁴, Jung Goo Lee⁵, Chong Guan Ng⁶, Zhen Wang⁷, Thomas Webb¹, Mami Kasahara-Kiritani⁸, Lawrence Vandervoort⁹, Vince Grillo⁹ (1. Janssen Asia Pacific, Singapore, Singapore, 2. School of Medicine, Deakin University, Victoria, Australia, 3. Department of Psychiatry, National Taiwan University Hospital Yunlin Branch, Yunlin County, Taiwan, 4. Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine, Tokyo, Japan, 5. Inje University Haeundai Paik Hospital, Busan, South Korea, 6. Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia, 7. Shanghai Mental Health Center, Xuhui District, Shanghai, China, 8. Janssen Pharmaceutical K.K., Tokyo, Japan, 9. Cerner Enviza, Singapore)

Session information